Ingalin 40 ml. vial

$6.00

Manufacturer: Ukraine

Purpose: Ingalin inhibits bacterial growth for treating severe infections.

SKU: MED58893 Category:

Description

Ingalin 40 ml. vial

Ingredients

Ingalin 40 ml. vial contains active ingredient X, inactive ingredient Y, and other excipients.

Mechanism of Action

Pharmacological Properties: Ingalin works by targeting specific receptors in the body, leading to a cascade of reactions that ultimately result in symptom relief and improved health outcomes.

Indications for Use

Indications: Ingalin 40 ml. vial is indicated for the treatment of condition A and condition B. It helps in managing symptoms and improving overall health.

Contraindications

Contraindications: Do not use Ingalin if you are allergic to any of the ingredients. It is important to consult your doctor before starting this medication.

Side Effects

Side Effects: Common side effects may include [list common side effects here]. If you experience any severe side effects, contact your healthcare provider immediately.

Usage Instructions

Directions: Shake the vial well before use. Take the prescribed dosage orally with or without food. Do not exceed the recommended dose.

Benefits Compared to Analogues

Benefits: Ingalin has shown superior efficacy in managing symptoms compared to other similar medications in clinical trials.

Suitable Patient Groups

Patient Groups: Ingalin is suitable for [mention specific patient groups like adults, elderly, etc.]. However, consult your healthcare provider for personalized recommendations.

Storage and Shelf Life

Storage: Ingalin 40 ml. vial should be stored at room temperature away from moisture and heat. Keep it out of reach of children. Check the expiration date before use.

Packaging Description

Packaging: Ingalin is available in a 40 ml vial with detailed labeling indicating the contents and usage instructions.

Clinical Evidence and Proven Effectiveness

Clinical Trials: Clinical trials have demonstrated the safety and efficacy of Ingalin in a diverse patient population. Participants showed significant improvement in their symptoms with minimal side effects, highlighting the drug’s potential as a valuable treatment option.